Novartis Investigative Site

Las Palmas de Gran Canaria, Las Palmas de G.C 35020

0 studies enrolling now · 4 studies all time

What they study most

Acute Heart Failure, Chronic Plaque Type Psoriasis, Heart Failure With Reduced Ejection Fraction (HF-rEF), Moderate to Severe Palmoplantar Psoriasis

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis — Completed
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed